OxyContin patent expiry poses tough choice for Ottawa – CBC.ca

HDownload Audio

by NationTalk on November 8, 2012744 Views

The federal health minister has until Nov. 25 to decide whether to allow drug companies to make a generic version of the painkiller OxyContin.

The patent on the brand name version of that drug expires on that date and generic drug companies have already signalled an interest in making the opiate, known by the non-brand name oxycodone.

But Purdue Pharma, the company that makes the drug, pulled OxyContin in March over concerns that it was being abused by drug users who altered it to make it more potent. The company replaced the drug with a new formulation called OxyNeo.

Read more: http://www.cbc.ca/news/health/story/2012/11/07/pol-oxycontin-oxyneo-generics.html

Send To Friend Email Print Story

Comments are closed.

NationTalk Partners & Sponsors Learn More